Response to erenumab assessed by HIT-6 is modulated by genetic factors and arterial hypertension - an explorative cohort study.

Chiara ZeccaSalvatore TerrazzinoDavide ParaGiovanna CampagnaMichele VianaChristoph J SchankinClaudio Gobbi

Published in: European journal of neurology (2023)

Response to ERE was associated with comorbid hypertension and specific allelic variants at CALCRL and RAMP1 genes. Results require confirmation in future studies.

Keyphrases

arterial hypertension
genome wide
copy number
current status
dna methylation
blood pressure
case control
genome wide identification
bioinformatics analysis
gene expression